Literature DB >> 9458802

Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung.

T S Brannon1, A N MacRitchie, M A Jaramillo, T S Sherman, I S Yuhanna, L R Margraf, P W Shaul.   

Abstract

Prostacyclin is a key mediator of pulmonary vascular and parenchymal function during late fetal and early postnatal life, and its synthesis in whole lung increases during that period. The rate-limiting enzyme in prostacyclin synthesis in the developing lung is cyclooxygenase (COX). We investigated the ontogeny and cellular localization of COX-1 (constitutive) and COX-2 (inducible) gene expression in lungs from late-gestation fetal lambs, 1-wk-old newborn lambs (NB1), and 1- to 4-mo-old newborn lambs (NB2). COX-1 mRNA abundance rose progressively from fetal to NB1 to NB2, increasing 12-fold overall. In parallel, immunoblot analysis revealed a progressive increase in COX-1 protein, rising fourfold from fetal lambs to NB2. COX-2 mRNA levels increased fivefold from fetal to NB1 but were similar in NB1 and NB2. However, COX-2 protein was not detectable by immunoblot analysis in any age group. Immunohistochemistry for COX-1 showed intense immunostaining in endothelial cells at all ages. COX-1 was also expressed in airway epithelium at all ages, with a greater number of epithelial cells staining positively in NB2 compared with fetal and NB1 groups. In addition, COX-1 was expressed in airway smooth muscle from NB1. COX-2 immunostaining was absent in all age groups. These findings indicate that there is differential expression of COX-1 and COX-2 in the developing lung and that the enzymes are expressed in a cell-specific manner. The developmental upregulation in COX-1 may optimize the capacity for prostaglandin-mediated vasodilation, bronchodilation, and surfactant synthesis in the newborn lung.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458802     DOI: 10.1152/ajplung.1998.274.1.L66

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Authors:  Nicolas F M Porta; Robin H Steinhorn
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

Review 2.  Neonatal pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

3.  Length oscillation induces force potentiation in infant guinea pig airway smooth muscle.

Authors:  Lu Wang; Pasquale Chitano; Thomas M Murphy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-03       Impact factor: 5.464

Review 4.  Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.

Authors:  Kathryn N Farrow; Robin H Steinhorn
Journal:  Handb Exp Pharmacol       Date:  2011

5.  Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.

Authors:  Zaher A Radi; David K Meyerholz; Mark R Ackermann
Journal:  Viral Immunol       Date:  2010-02       Impact factor: 2.257

Review 6.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 7.  Three paradigms of airway smooth muscle hyperresponsiveness in young guinea pigs.

Authors:  Pasquale Chitano; Lu Wang; Thomas M Murphy
Journal:  Can J Physiol Pharmacol       Date:  2007-07       Impact factor: 2.273

8.  Maturation of intracellular calcium homeostasis in sheep pulmonary arterial smooth muscle cells.

Authors:  Ravi Goyal; Kara D Creel; Erica Chavis; Gregory D Smith; Lawrence D Longo; Sean M Wilson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-05       Impact factor: 5.464

9.  Diagnosis and treatment of pulmonary hypertension in infancy.

Authors:  Robin H Steinhorn
Journal:  Early Hum Dev       Date:  2013-09-29       Impact factor: 2.079

Review 10.  Modulation of pulmonary vasomotor tone in the fetus and neonate.

Authors:  N S Ghanayem; J B Gordon
Journal:  Respir Res       Date:  2001-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.